|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/16 | |||
| A61K 31/55 | |||
| A61K 9/14 |
| (11) | Number of the document | 2941242 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13829043.2 |
| Date of filing the European patent application | 2013-12-27 | |
| (97) | Date of publication of the European application | 2015-11-11 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2013/085355 |
| Date | 2013-12-27 |
| (87) | Number | WO 2014/104412 |
| Date | 2014-07-03 |
| (30) | Number | Date | Country code |
| 201261747005 P | 2012-12-28 | US |
| (72) |
KANEKO, Daiki, JP
MATSUDA, Takakuni, JP
MIYATA, Kenichi, JP
SUZUKI, Kai, JP
FUJIKI, Hiroyuki, JP
KINOSHITA, Shizuo, JP
OHMOTO, Koji, JP
AIHARA, Miki, JP
|
| (73) |
Otsuka Pharmaceutical Co., Ltd.,
9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535,
JP
|
| (54) | INJECTABLE DEPOT FORMULATION COMPRISING OPTICALLY ACTIVE TOLVAPTAN AND PROCESS OF PRODUCING THE SAME |
| INJECTABLE DEPOT FORMULATION COMPRISING OPTICALLY ACTIVE TOLVAPTAN AND PROCESS OF PRODUCING THE SAME |